AbbVie : FDA Oks Expanded BOTOX Label For Treatment Of Pediatric Patients With Spasticity

(RTTNews) – Allergan, an AbbVie (ABBV) company, said that the U.S. Food and Drug Administration approved a supplemental Biologics License Application or sBLA that supports expanded use of BOTOX for …
( read original story …)


Advertisement